Bone health in cancer: ESMO Clinical Practice Guidelines

被引:289
|
作者
Coleman, R. [1 ]
Hadji, P. [2 ,3 ]
Body, J-J [4 ]
Santini, D. [5 ]
Chow, E. [6 ]
Terpos, E. [7 ]
Oudard, S. [8 ]
Bruland, O. [9 ,10 ]
Flamen, P. [11 ]
Kurth, A. [12 ,13 ]
Van Poznak, C. [14 ]
Aapro, M. [15 ]
Jordan, K. [16 ]
机构
[1] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England
[2] Frankfurt Ctr Bone Hlth, Frankfurt, Germany
[3] Philipps Univ Marburg, Marburg, Germany
[4] Univ Libre Bruxelles, CHU Brugmann, Brussels, Belgium
[5] Univ Campus Biomed, Med Oncol Dept, Rome, Italy
[6] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[7] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece
[8] Paris Descartes Univ, Georges Pompidou Hosp, Dept Med Oncol, Paris, France
[9] Univ Oslo, Inst Clin Med, Oslo, Norway
[10] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway
[11] Univ Libre Bruxelles, Inst Jules Bordet, Dept Nucl Med, Brussels, Belgium
[12] Community Clin Middle Rhine, Dept Orthopaed & Trauma Surg, Campus Kemperhof, Koblenz, Germany
[13] Univ Med Mainz, Major Teaching Hosp, Mainz, Germany
[14] Univ Michigan, Ann Arbor, MI 48109 USA
[15] Genolier Canc Ctr, Genolier, Switzerland
[16] Heidelberg Univ, Dept Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany
关键词
bone metastases; cancer treatment-induced bone loss; bone-targeted agents; Clinical Practice Guidelines; diagnosis; treatment; follow-up; EARLY BREAST-CANCER; ZOLEDRONIC ACID; MULTIPLE-MYELOMA; DOUBLE-BLIND; SOLID TUMORS; OPEN-LABEL; DENOSUMAB; METASTASES; PHASE-3; SURVIVAL;
D O I
10.1016/j.annonc.2020.07.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1650 / 1663
页数:14
相关论文
共 50 条
  • [21] Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines
    Larkin, P. J.
    Cherny, N. I.
    La Carpia, D.
    Guglielmo, M.
    Ostgathe, C.
    Scotte, F.
    Ripamonti, C. I.
    ANNALS OF ONCOLOGY, 2018, 29 : 111 - 125
  • [22] Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
    Aapro, M.
    Beguin, Y.
    Bokemeyer, C.
    Dicato, M.
    Gascon, P.
    Glaspy, J.
    Hofmann, A.
    Link, H.
    Littlewood, T.
    Ludwig, H.
    Osterborg, A.
    Pronzato, P.
    Santini, V.
    Schrijvers, D.
    Stauder, R.
    Jordan, K.
    Herrstedt, J.
    ANNALS OF ONCOLOGY, 2018, 29 : 96 - 110
  • [23] Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment
    Fabi, A.
    Bhargava, R.
    Fatigoni, S.
    Guglielmo, M.
    Horneber, M.
    Roila, F.
    Weis, J.
    Jordan, K.
    Ripamonti, C., I
    ANNALS OF ONCOLOGY, 2020, 31 (06) : 713 - 723
  • [24] Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines
    Crawford, G. B.
    Dzierzanowski, T.
    Hauser, K.
    Larkin, P.
    Luque-Blanco, A. I.
    Murphy, I.
    Puchalski, C. M.
    Ripamonti, C. I.
    ESMO OPEN, 2021, 6 (04)
  • [25] Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines
    Mandala, M.
    Falanga, A.
    Roila, F.
    ANNALS OF ONCOLOGY, 2011, 22 : vi85 - vi92
  • [26] Bone Cancer Clinical Practice Guidelines in Oncology
    Biermann, J. Sybil
    Adkins, Douglas R.
    Agulnik, Mark
    Benjamin, Robert S.
    Brigman, Brian
    Butrynski, James E.
    Cheong, David
    Chow, Warren
    Curry, William T.
    Frassica, Deborah A.
    Frassica, Frank J.
    Hande, Kenneth R.
    Hornicek, Francis J.
    Jones, Robin L.
    Mayerson, Joel
    McGarry, Sean V.
    McGrath, Brian
    Morris, Carol D.
    O'Donnell, Richard J.
    Randall, R. Lor
    Santana, Victor M.
    Satcher, Robert L.
    Siegel, Herrick J.
    von Mehren, Margaret
    Bergman, Mary Anne
    Sundar, Hema
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (06): : 688 - 723
  • [27] Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
    Klastersky, J.
    de Naurois, J.
    Rolston, K.
    Rapoport, B.
    Maschmeyer, G.
    Aapro, M.
    Herrstedt, J.
    ANNALS OF ONCOLOGY, 2016, 27 : v111 - v118
  • [28] Management of febrile neutropenia: ESMO Clinical Practice Guidelines
    de Naurois, J.
    Novitzky-Basso, I.
    Gill, M. J.
    Marti, F. Marti
    Cullen, M. H.
    Roila, F.
    ANNALS OF ONCOLOGY, 2010, 21 : v252 - v256
  • [29] ESMO Clinical Practice Guidelines: development, implementation and dissemination
    Pavlidis, N.
    Hansen, H.
    Stahel, R.
    ANNALS OF ONCOLOGY, 2010, 21 : v7 - v8
  • [30] Hodgkin Lymphoma: Comments on ESMO Clinical Practice Guidelines
    Aurer, Igor
    Zing, Natalia
    Federico, Massimo
    HEMASPHERE, 2020, 4 (04):